Labshake search
Citations for Stemcell Technologies :
1 - 50 of 345 citations for SARS CoV 2 Spike E M Mosaic Protein His tag E. coli since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 0.1 µM Compound-E (StemCell Technologies), 2ng/mL BDNF ...
-
bioRxiv - Neuroscience 2023Quote: ... Compound E (0.1 μM; STEMCELL Technologies), db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2023Quote: ... and Compound E (73952, StemCell Technologies) using the protocol 26 ...
-
bioRxiv - Cell Biology 2022Quote: ... Compound E (0.1 μM; STEMCELL Technologies; 73954), db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2022Quote: ... 0.2 µM Compound E (Stem Cell Technologies), 1 µg/mL Laminin (R&D ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 µM Compound E (Stem Cell Technologies). On day 3 ...
-
bioRxiv - Neuroscience 2021Quote: ... 2mM Dorsomorphin (Miltenyi) and 0.1mM Compound E (StemCell Technologies). Medium was changed daily for 2 days ...
-
bioRxiv - Neuroscience 2024Quote: ... 0.1 µM Compound E (CpdE, StemCell Technologies; Cat#73954), and 10 ng/ml insulin-like growth factor-1 (IGF-1 ...
-
bioRxiv - Immunology 2021Quote: ... Hybridomas were thawed and expanded in ClonaCell-HY Growth Medium E (Stem Cell Technologies) up to a volume of 300ml ...
-
bioRxiv - Immunology 2019Quote: ... before centrifugation and resuspension in Clonacell-HY Medium E (StemCell Technologies, Vancouver, BC, Canada) supplemented with HAT (Sigma-Aldrich ...
-
bioRxiv - Immunology 2021Quote: The 7D9 hybridoma line was cultured in ClonaCell™-HY Medium E (STEMCELL Technologies) prior to antibody production ...
-
bioRxiv - Immunology 2021Quote: ... The selected cloned cell lines secreting mAb H5.28 or H5.31 were grown initially in hybridoma growth medium (ClonaCell-HY medium E from STEMCELL Technologies). Prior to antibody expression and purification ...
-
bioRxiv - Immunology 2020Quote: ... and cells from wells with reactive supernatants were expanded to 48-well plates for 1 week in 0.5 mL of StemCell medium E (StemCell Technologies), before being screened again by ELISA ...
-
bioRxiv - Immunology 2022Quote: ... and cells from wells with reactive supernatants were expanded to 48-well plates for 1 week in 0.5 mL of StemCell medium E (StemCell Technologies), before being screened again by ELISA ...
-
bioRxiv - Neuroscience 2019Quote: ... media was supplemented with Y27632, Laminin (2.5 µg per 1ml of media, Thermo-Fisher) and 0.1µM Compound-E (Stem Cell Technologies, Grenoble, France) during the first 3 days after plating in Poly-L-Lysine (Sigma ...
-
bioRxiv - Immunology 2021Quote: ... CD34+ umbilical cord and CD34+ hematopoietic stem/progenitor cell (Ethics Committee Salzburg approval 415-E/1776/4-2014) were isolated using density gradient centrifugation (Lymphoprep; Stemcell Technologies). Primary human cells ...
-
bioRxiv - Immunology 2019Quote: ... A total of 649 IgGpos/OVApos hybridoma cells were individually deposited into 96-well plates containing Medium E (StemCell Technologies, Vancouver, BC, Canada). Supernatants were screened by ELISA against OVA seven days after sorting ...
-
bioRxiv - Neuroscience 2023Quote: ... On day 3 cells were changed into a 50/50 ratio of fibroblast media and TeSR™ E-7™ Reprogramming Media (STEMCELL Technologies), and on day 5 were changed into 100% E-7™ Reprogramming Media ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 M ascorbic acid (STEMCELL Technologies).
-
bioRxiv - Microbiology 2022Quote: ... differentiated with 25 ng/mL m-CSF (StemCell Technologies), and maintained at 37°C in 5% CO2.
-
bioRxiv - Cancer Biology 2023Quote: ... with 10-6 M hydrocortisone (07904, Stem Cell Technologies), 1% penicillin streptomycin and 1ng/mL IL- 3 (R&D) ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 1x10-6 M hydrocortisone (StemCell Technologies, 74142), with half media exchanges twice per week.
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10-6 M hydrocortisone (74142, Stem Cell Technologies) and 1% penicillin streptomycin ...
-
bioRxiv - Biophysics 2023Quote: ... and the media further supplemented with 30 U mL-1 of human recombinant IL-2 protein (STEMCELL Technologies, USA). T cells were incubated in a humidified incubator with 5% CO2 at 37°C and were split to 0.5×106 cells mL-1 when their concentration surpassed 2.5×106 cells per well or when medium became depleted (turning yellow in color) ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 50 ng/uL Human Recombinant M-CSF (STEMCELL Technologies) for 4 days ...
-
bioRxiv - Molecular Biology 2020Quote: ... and 10-M RHO/ROCK pathway inhibitor Y-276932 (STEMCELL Technologies Cat# 72304) were used to dissociate iPSCs to single cells during passaging ...
-
bioRxiv - Cell Biology 2023Quote: ... and resuspended in media supplemented with 10$M ROCK inhibitor Y27632 (STEMCELL Technologies). Cells were then seeded onto Geltrex-coated plates (12-well ...
-
bioRxiv - Microbiology 2023Quote: ... 2 µl of 2% rat serum (Stemcell technologies) was added to each well for 15 minutes at room temperature and proceeded to further staining without a washing step.
-
bioRxiv - Bioengineering 2021Quote: ... 0.12 M and 15 % sucrose and placed on an organoid embedding sheet (StemCell Technologies, 68579A). The drop of gelatin was left to harden at 4 °C for 15 min ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Bioengineering 2019Quote: ... or APEL 2 (STEMCELL Technologies) media without ROCK inhibitor and plates were placed onto LAVA illumination devices and subjected to experimental conditions ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM XAV939 (STEMCELL Technologies), 10 µM SB431542 hydrate and 2 µg/mL doxycycline hyclate (Sigma) ...
-
bioRxiv - Pathology 2022Quote: ... 2 µM CHIR99021 (StemCell Technologies), and 10 ng/mL Recombinant Human BMP-7(Peprotech) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2% SM1 (Stem Cell Technologies), 15mM HEPES (Gibco) ...
-
bioRxiv - Neuroscience 2023Quote: ... IWP-2 (STEMCELL Technologies, 72124), RA (Sigma ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μM SB431542 (StemCell Technologies), 1 μM DMH1 (Tocris Bioscience) ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% SM1 (05711, STEMCell Technologies), 1% N2 (07152 ...
-
bioRxiv - Immunology 2024Quote: ... mice and bone marrow progenitors were plated on non- tissue treated dishes and differentiated into BMDM during a 6-day culture in complete Dulbecco’s modified Eagle’s medium (DMEM) containing 5% FBS and supplemented with 60 ng/ml recombinant murine M-CSF (Stemcell Technologies) in a water saturated atmosphere at 37°C ...
-
bioRxiv - Bioengineering 2021Quote: ... 2 μg/ml Heparin (STEMCELL Technologies), 20 ng/ml bFGF (Millipore) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/ml heparin (StemCell Technologies), epidermal growth factor (EGF ...
-
bioRxiv - Neuroscience 2020Quote: ... 2% NeuroCult SM1 supplement (STEMCELL Technologies), 2 mM GlutaMax.
-
bioRxiv - Developmental Biology 2020Quote: ... 10ng/mL FGF-2 (StemCell Technology), and 5nM Rock inhibitor ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM SB431542 (StemCell Technologies). Cells were maintained in NbM for 6 days after which they were passaged with 1 U/mL Dispase (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% SM1 (Stemcell Technologies, Vancouver, Canada), and 5 μM cytosine β-d-arabinofuranoside (AraC ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2 μg/ml heparin (Stemcell Technologies), 50 units/ml penicillin ...
-
bioRxiv - Neuroscience 2023Quote: ... B27 (2%v/v, Stemcell technologies), N2 (0.5%v/v ...